Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

37.17USD
3:31pm GMT
Change (% chg)

$-0.19 (-0.51%)
Prev Close
$37.36
Open
$37.36
Day's High
$37.36
Day's Low
$37.00
Volume
8,433
Avg. Vol
47,271
52-wk High
$42.00
52-wk Low
$19.34

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Michael Wolff Jensen

42 2013 Chairman of the Board, Senior Vice President, General Counsel

Jan Moeller Mikkelsen

56 2007 President, Chief Executive Officer, Director

Scott Smith

2016 Chief Financial Officer, Senior Vice President

Lotte Soenderbjerg

53 2007 Senior Vice President, Chief Administrative Officer

Harald Rau

45 2007 Senior Vice President, Chief Scientific Officer